Identity
- Device Name
- Latex Examination Gloves (Latex Powder Free) EUDAMED
- Model / Reference
- LPF EUDAMED
Identifiers
- Primary DI / UDI-DI
- 09555954300221 EUDAMED09555954300252 EUDAMED09555954300214 EUDAMED09555954300245 EUDAMED09555954300238 EUDAMED
- Basic UDI-DI
- 955595430LPFUT EUDAMED
- Direct Marketing DI
- 09555954300221 EUDAMED09555954300252 EUDAMED09555954300214 EUDAMED09555954300245 EUDAMED09555954300238 EUDAMED
- EMDN Code
- T010201 LATEX EXAMINATION / TREATMENT GLOVES EUDAMED
Classification
- Device Class
- Class I EUDAMED
- Market of Registration
- Germany EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
Yes
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Latex Examination Gloves (Latex Powder Free) by Apex Glove Sdn Bhd — Class I — MDR — listed in EUDAMED — regulatory data on deviCERTS
Manufacturer's product page: High Risk Latex Gloves
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | 955595430LPFUT | Class I | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Apex Glove Sdn Bhd
- EUDAMED SRN
- MY-MF-000049917
- Authorised Representative
- MedNet EC-REP GmbH DE-AR-000000002
Sources (5)
- EUDAMED a2b7234e-72e7-4fc9-980c-f35a14e8b208 61 fields · synced Jul 30, 2026
- EUDAMED a1c641f3-6da9-4bb9-8774-3a09fdca503a 61 fields · synced May 17, 2026
- EUDAMED aa473692-4cea-448c-a46d-4be7d829e7c8 61 fields · synced May 17, 2026
- EUDAMED 32f3f054-9264-4eab-bde3-3e4f5e5207d0 61 fields · synced May 19, 2026
- EUDAMED 54d0a1f1-51db-456a-82a2-eb440b171b66 61 fields · synced May 19, 2026